Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Zylö Therapeutics has an innovative sustained-release topical delivery system that was developed by Joel Friedman MD PhD, Adam Friedman MD FAAD, and Andrew Draganski PhD. The delivery system uses patented xerogel-derived silica particles, called Z-pods™, to deliver—in a sustained and controlled manner—notoriously hard-to-deliver therapeutic agents through topical administration. The human body needs Nitric Oxide [NO],...
Zylö Therapeutics has an innovative sustained-release topical delivery system that was developed by Joel Friedman MD PhD, Adam Friedman MD FAAD, and Andrew Draganski PhD. The delivery system uses patented xerogel-derived silica particles, called Z-pods™, to deliver—in a sustained and controlled manner—notoriously hard-to-deliver therapeutic agents through topical administration. The human body needs Nitric Oxide [NO], but produces it at a declining rate, such that a 60-year-old is at about 15%; this results in a range of disorders including stamina issues, cardiovascular issues, wound-healing issues, and ED issues.

List your booth number for exhibitions, ask us